Inventiva (IVA) Operating Income (2019 - 2021)
Inventiva (IVA) recorded quarterly Operating Income of -$16.5 million in Q2 2021, down 37.21% quarter-over-quarter from -$12.0 million in Q1 2021, and down 68.62% on a YoY basis from -$52.4 million in Q2 2020.
Inventiva (IVA) Operating Income (2019 - 2021) Analysis & Trends
Inventiva's Operating Income history runs 3 years deep, the most recent figure standing at -$16.5 million for Q2 2021.
- In Q2 2021, Operating Income fell 68.62% year-over-year to -$16.5 million; the TTM figure through Jun 2021 stood at -$73.6 million (changed N/A YoY), while the FY2025 annual figure was -$164.1 million, down 57.45% from the prior year.
- Operating Income was -$16.5 million for Q2 2021 at Inventiva, down from -$12.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$7.5 million in Q1 2020 to a low of -$35.4 million in Q4 2020.
- Historically, Operating Income has averaged -$19.1 million across 3 years, with a median of -$14.2 million in 2021.
- The sharpest annual moves came in 2020 and 2021: Operating Income decreased 5.6% in 2020, then slumped 68.62% in 2021.
- A 3-year view of Operating Income shows it stood at -$33.6 million in 2019, then dropped by 5.6% to -$35.4 million in 2020, then surged by 53.56% to -$16.5 million in 2021.
- The last three Operating Income figures came in at -$16.5 million (Q2 2021), -$12.0 million (Q1 2021), and -$35.4 million (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |